<DOC>
	<DOC>NCT02183116</DOC>
	<brief_summary>To Access the Efficacy and Safety of Meloxicam 7.5mg once daily over a treatment period of 56 days</brief_summary>
	<brief_title>A Study to Access the Efficacy and Safety of Meloxicam in Patients With Osteoarthritis of the Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis, Knee</mesh_term>
	<mesh_term>Meloxicam</mesh_term>
	<criteria>Osteoarthritis of the knee requiring the therapy with nonsteroidal antiinflammatory drugs (NSAIDs)</criteria>
	<gender>All</gender>
	<minimum_age>34 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>